Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

dysostoses/phosphatase

L'enllaç es desa al porta-retalls
ArticlesAssaigs clínicsPatents
9 resultats

[Immunological reactivity and serum biochemical indices in patients with otofacial dysostosis (first and second arch syndrome)].

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The examination of 50 patients aged from 6 to 35 has first revealed a pronounced disorder of the indices of immunity and biochemical composition of blood (decreased level of aminotransferases, cholesterol, increased content of alkaline phosphatase) in patients with otomandibular dysostosis.

Cementum analysis in cleidocranial dysostosis.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
OBJECTIVE Cleidocranial dysostosis (CCD) is a skeletal disorder associated with dental anomalies such as failure or delayed eruption of permanent teeth and multiple impacted supernumerary or permanent teeth. Absence of cellular cementum at the root apex is presumed to be one of the factors for

An inherited FGFR2 mutation increased osteogenesis gene expression and result in Crouzon syndrome.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND FGFR2 encodes a fibroblast growth factor receptor whose mutations are responsible for the Crouzon syndrome, involving craniosynostosis and facial dysostosis with shallow orbits. However, few reports are available quantifying the orbital volume of Crouzon syndrome and there was little

Teratological studies on craniofacial malformations.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Craniofacial malformations cause great human suffering. The purpose of the experimental studies was to investigate teratogenically induced craniofacial malformations in the rat, and to study if vitamin B6 could prevent the teratogenically induced malformations in the rat. The aim of the clinical

Rickets-like radiological and biochemical features of neonatal mucolipidosis II (I-cell disease): report of two cases.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
In this paper, two cases with mucolipidosis type II (I-cell disease) (proven in one presenting newborn and presumed in an elder deceased brother) are presented. These infants showed severe skeletal changes with diffuse periosteal new bone formation in long bones and ribs, marked osteopenia, and

Acrodysostosis associated with hypercalcemia.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
An 18-year-old man was admitted to the clinic complaining of deterioration in the function of his hands and feet. The clinical examination revealed that his movements were clumsy and that he had disproportionally short limbs. In addition, he also had facial abnormalities of frontal bossing,

Mucolipidosis II presenting as severe neonatal hyperparathyroidism.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Mucolipidosis II (ML II or I-cell disease ) (OMIM 252500) is an autosomal recessive lysosomal enzyme targeting disorder that usually presents between 6 and 12 months of age with a clinical phenotype resembling Hurler syndrome and a radiological picture of dysostosis multiplex. When ML II is severe

A case of mucolipidosis II presenting with prenatal skeletal dysplasia and severe secondary hyperparathyroidism at birth.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Mucolipidosis II (ML II) or inclusion cell disease (I-cell disease) is a rarely occurring autosomal recessive lysosomal enzyme-targeting disease. This disease is usually found to occur in individuals aged between 6 and 12 months, with a clinical phenotype resembling that of Hurler syndrome and

Sea-blue histiocyte syndrome with bone anomalies.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Two sisters, now 29 and 24 years old, are described. They presented a congenital storage of, most probably, phospholipids in the histiocytes of the sea-blue type or blue pigmentophages. The granules of these cells showed a PAS positivity and strong positivity for acid phosphatase, but there were
Uneix-te a la nostra
pàgina de Facebook

La base de dades d’herbes medicinals més completa avalada per la ciència

  • Funciona en 55 idiomes
  • Cures a base d'herbes recolzades per la ciència
  • Reconeixement d’herbes per imatge
  • Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
  • Llegiu publicacions científiques relacionades amb la vostra cerca
  • Cerqueu herbes medicinals pels seus efectes
  • Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents

Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades

Google Play badgeApp Store badge